Neuberger Berman Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,837
Closed -$144K 1830
2017
Q3
$144K Sell
18,837
-87,920
-82% -$584K ﹤0.01% 1561
2017
Q2
$759K Buy
106,757
+58,814
+123% +$269K ﹤0.01% 1222
2017
Q1
$186K Buy
47,943
+3,616
+8% +$10.6K ﹤0.01% 1543
2016
Q4
$90K Buy
44,327
+5,106
+13% +$10.3K ﹤0.01% 1572
2016
Q3
$105K Sell
39,221
-2,387
-6% -$6.94K ﹤0.01% 1563
2016
Q2
$128K Sell
41,608
-3,336
-7% -$20.9K ﹤0.01% 1499
2016
Q1
$383K Sell
44,944
-15,509
-26% -$131K ﹤0.01% 1319
2015
Q4
$820K Sell
60,453
-4,129
-6% -$50.8K ﹤0.01% 1166
2015
Q3
$620K Sell
64,582
-4,649
-7% -$68K ﹤0.01% 1251
2015
Q2
$996K Buy
69,231
+7,136
+11% +$78.4K ﹤0.01% 1210
2015
Q1
$556K Buy
62,095
+37,157
+149% +$269K ﹤0.01% 1325
2014
Q4
$152K Buy
24,938
+164
+0.7% +$1.5K ﹤0.01% 1587
2014
Q3
$262K Buy
24,774
+4,850
+24% +$54.9K ﹤0.01% 1495
2014
Q2
$236K Sell
19,924
-3,068
-13% -$38.5K ﹤0.01% 1575
2014
Q1
$343K Buy
22,992
+1,755
+8% +$27.7K ﹤0.01% 1409
2013
Q4
$312K Buy
21,237
+58
+0.3% +$891 ﹤0.01% 1424
2013
Q3
$360K Buy
21,179
+77
+0.4% +$1.35K ﹤0.01% 1376
2013
Q2
$350K Buy
+21,102
New +$342K ﹤0.01% 1369

Other funds holding IMGN

Neuberger Berman Group's IMGN Position: Q4 2017 in Review

Neuberger Berman Group sold out of Immunogen Inc (IMGN) in Q4 2017, closing a stake of 18,837 shares — an estimated $144K sold.

Neuberger Berman Group first reported a position in IMGN in Q2 2013 and held it in 18 quarters. The position peaked at $996K in Q2 2015. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Neuberger Berman Group reported no remaining Immunogen Inc position as of Q4 2017 after selling out during the quarter.
  • Neuberger Berman Group sold 18,837 Immunogen Inc shares in Q4 2017, an estimated $144K.
  • Neuberger Berman Group first reported a position in Immunogen Inc in Q2 2013 and held it in 18 quarters.
  • Neuberger Berman Group's Immunogen Inc position peaked at $996K in Q2 2015.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Neuberger Berman Group's 13F filing for Q4 2017, filed 14 Feb 2018.